Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1981 Feb;43(2):157–168. doi: 10.1038/bjc.1981.24

In vitro stimulation of cell-mediated cytotoxicity by acute leukaemias.

G M Taylor
PMCID: PMC2010526  PMID: 6451236

Abstract

Acute leukaemias stimulated proliferative and cell-mediated cytotoxic (CMC) responses in vitro in normal (unprimed) lymphocytes. Proliferation was detected by increases in viable cell counts and [3H]dT incorporation in mixed lymphocyte-leukaemia-cell cultures. CMC detected on cultured cell-line targets (CCL) including K562 was generally much stronger than on fresh leukaemia cells, and correlated with stimulation of [3H]dT uptake in the responding lymphocytes. Leukaemias which were resistant as targets to CMC were able competitively to inhibit CMC on K562, though not as efficiently as blocking by K562 itself. With one leukaemia, blocking of CMC increased as the level of CMC on K562 was amplified by greater numbers of stimulating cells in the sensitization phase. This suggests that in certain cases blocking of effector cells by acute-leukaemia cells may depend upon the state of activation of the effector cells. Lymphocytes from a leukaemia patient in remission, treated with allogeneic leukaemia-cell immunotherapy and stimulated in vitro with immunizing leukaemia cells, developed strong anti-leukaemic CMC. A non-immunized patient's lymphocytes did not respond in this way, despite comparable levels of CMC on K562 in both patients. Dual stimulation of unprimed normal lymphocytes and remission lymphocytes with allogeneic or autologous leukaemias and various cell lines, amplified anti-leukaemic CMC, but did not markedly alter CMC or CCL. These data do not formally exclude the mediation of in vitro-stimulated anti-leukaemic CMC by NK-like cells, but suggest that such effector cells differ qualitatively from NK-like cells detected in the absence of anti-leukaemic CMC.

Full text

PDF
157

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson L. C., Nilsson K., Gahmberg C. G. K562--a human erythroleukemic cell line. Int J Cancer. 1979 Feb;23(2):143–147. doi: 10.1002/ijc.2910230202. [DOI] [PubMed] [Google Scholar]
  2. Bakacs T., Gergely P., Klein E. Characterization of cytotoxic human lymphocyte subpopulations: the role of Fc-receptor-carrying cells. Cell Immunol. 1977 Aug;32(2):317–328. doi: 10.1016/0008-8749(77)90208-8. [DOI] [PubMed] [Google Scholar]
  3. Callewaert D. M., Kaplan J., Peterson W. D., Jr, Lightbody J. J. Spontaneous cytotoxicity of human lymphoblast cell lines mediated by normal peripheral blood lymphocytes. I. Differential susceptibility of T-versus B-cell lines. Cell Immunol. 1977 Sep;33(1):11–19. doi: 10.1016/0008-8749(77)90130-7. [DOI] [PubMed] [Google Scholar]
  4. Callewaert D. M., Lightbody J. J., Kaplan J., Jaroszewski J., Peterson W. D., Jr, Rosenberg J. C. Cytotoxicity of human peripheral lymphocytes in cell-mediated lympholysis; antibody-dependent cell-mediated lympholysis and natural cytotoxicity assays after mixed lymphocyte culture. J Immunol. 1978 Jul;121(1):81–85. [PubMed] [Google Scholar]
  5. Gifford G. E., Tibor A., Peavy D. L. Interferon production in mixed lymphocyte cell cultures. Infect Immun. 1971 Jan;3(1):164–166. doi: 10.1128/iai.3.1.164-166.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Harris R., Zuhrie S. R., Freeman C. B., Taylor G. M., MacIver J. E., Geary C. G., Delamore I. W., Hull P. J., Tooth J. A. Active immunotherapy in acute myelogenous leukaemia and the induction of second and subsequent remissions. Br J Cancer. 1978 Feb;37(2):282–288. doi: 10.1038/bjc.1978.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Herberman R. B., Holden H. T. Natural cell-mediated immunity. Adv Cancer Res. 1978;27:305–377. doi: 10.1016/s0065-230x(08)60936-7. [DOI] [PubMed] [Google Scholar]
  8. Herberman R. B., McCoy J. L., Levine P. H. Immunological reactions to tumor-associated antigens in Burkitts lymphoma and other lymphomas. Cancer Res. 1974 May;34(5):1222–1227. [PubMed] [Google Scholar]
  9. Heron I., Berg K., Cantell K. Regulatory effect of interferon on T cells in vitro. J Immunol. 1976 Oct;117(4):1370–1373. [PubMed] [Google Scholar]
  10. Jensen P. J., Koren H. S. Depletion of NK by cellular immunoadsorption. J Immunol. 1979 Sep;123(3):1127–1132. [PubMed] [Google Scholar]
  11. Jondal M., Spine C., Targan S. Human spontaneous killer cells selective for tumour-derived target cells. Nature. 1978 Mar 2;272(5648):62–64. doi: 10.1038/272062a0. [DOI] [PubMed] [Google Scholar]
  12. Jondal M., Targan S. In vitro induction of cytotoxic effector cells with spontaneous killer cell specificity. J Exp Med. 1978 Jun 1;147(6):1621–1636. doi: 10.1084/jem.147.6.1621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Julius M. H., Simpson E., Herzenberg L. A. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol. 1973 Oct;3(10):645–649. doi: 10.1002/eji.1830031011. [DOI] [PubMed] [Google Scholar]
  14. Kay H. D., Sinkovics J. G. Letter: Cytotoxic lymphocytes from normal donors. Lancet. 1974 Aug 3;2(7875):296–297. [PubMed] [Google Scholar]
  15. Kedar E., Raanan Z., Kafka I., Holland J. F., Bekesi G., Weiss D. W. In vitro induction of cytotoxic effector cells against human neoplasms. I. Sensitization conditions and effect of cryopreservation on the induction and expression of cytotoxic responses to allogeneic leukemia cells. J Immunol Methods. 1979;28(3-4):303–319. doi: 10.1016/0022-1759(79)90196-0. [DOI] [PubMed] [Google Scholar]
  16. Lee S. K., Oliver R. T. Autologous leukemia-specific T-cell-mediated lymphocytotoxicity in patients with acute myelogenous leukemia. J Exp Med. 1978 Mar 1;147(3):912–922. doi: 10.1084/jem.147.3.912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lozzio C. B., Lozzio B. B. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood. 1975 Mar;45(3):321–334. [PubMed] [Google Scholar]
  18. Moore M., Potter M. R. Enhancement of human natural cell-mediated cytotoxicity by interferon. Br J Cancer. 1980 Mar;41(3):378–387. doi: 10.1038/bjc.1980.61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Nelson D. L., Bundy B. M., Strober W. Spontaneous cell-mediated cytotoxicity by human peripheral blood lymphocytes in vitro. J Immunol. 1977 Oct;119(4):1401–1405. [PubMed] [Google Scholar]
  20. Orosz C. G., Finke J. H. Influence of killer assisting factor (KAF) on generation of cytotoxic T cells. Cell Immunol. 1978 Apr;37(1):86–95. doi: 10.1016/0008-8749(78)90176-4. [DOI] [PubMed] [Google Scholar]
  21. Pross H. F., Baines M. G., Jondal M. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. II. Is the complement receptor necessarily present on the killer cells? Int J Cancer. 1977 Sep 15;20(3):353–358. doi: 10.1002/ijc.2910200306. [DOI] [PubMed] [Google Scholar]
  22. Pross H. F., Jondal M. Cytotoxic lymphocytes from normal donors. A functional marker of human non-T lymphocytes. Clin Exp Immunol. 1975 Aug;21(2):226–235. [PMC free article] [PubMed] [Google Scholar]
  23. Rosenberg E. B., McCoy J. L., Green S. S., Donnelly F. C., Siwarski D. F., Levine P. H., Herberman R. B. Destruction of human lymphoid tissue-culture cell lines by human peripheral lymphocytes in 51Cr-release cellular cytotoxicity assays. J Natl Cancer Inst. 1974 Feb;52(2):345–352. doi: 10.1093/jnci/52.2.345. [DOI] [PubMed] [Google Scholar]
  24. Saksela E., Timonen T., Ranki A., Häyry P. Morphological and functional characterization of isolated effector cells responsible for human natural killer activity to fetal fibroblasts and to cultured cell line targets. Immunol Rev. 1979;44:71–123. doi: 10.1111/j.1600-065x.1979.tb00268.x. [DOI] [PubMed] [Google Scholar]
  25. Santoli D., Koprowski H. Mechanisms of activation of human natural killer cells against tumor and virus-infected cells. Immunol Rev. 1979;44:125–163. doi: 10.1111/j.1600-065x.1979.tb00269.x. [DOI] [PubMed] [Google Scholar]
  26. Seeley J. K., Golub S. H. Studies on cytotoxicity generated in human mixed lymphocyte cultures. I. Time course and target spectrum of several distinct concomitant cytotoxic activities. J Immunol. 1978 Apr;120(4):1415–1422. [PubMed] [Google Scholar]
  27. Simon P. L., Farrar J. J., Dind P. D. Biochemical relationship between murine immune interferon and a killer cell helper factor. J Immunol. 1979 Jan;122(1):127–132. [PubMed] [Google Scholar]
  28. Sondel P. M., O'Brien C., Porter L., Schlossman S. F., Chess L. Cell-mediated destruction of human leukemic cells by MHC identical lymphocytes: requirement for a proliferative trigger in vitro. J Immunol. 1976 Dec;117(6):2197–2203. [PubMed] [Google Scholar]
  29. Sopori M., Bernstein A., Bach F. H. In vitro sensitization of thymocytes. Role of H-21 I region determinants and cell-free mixed leukocyte culture supernates in generation of cytotoxic responses. J Exp Med. 1978 Oct 1;148(4):953–962. doi: 10.1084/jem.148.4.953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Taylor G. M., Harris R., Freeman C. B. Cell-mediated cytotoxicity as a result of immunotherapy in patients with acute myeloid leukaemia. Br J Cancer. 1976 Feb;33(2):137–143. doi: 10.1038/bjc.1976.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Trinchieri G., Santoli D. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis. J Exp Med. 1978 May 1;147(5):1314–1333. doi: 10.1084/jem.147.5.1314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Trinchieri G., Santoli D., Dee R. R., Knowles B. B. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation. J Exp Med. 1978 May 1;147(5):1299–1313. doi: 10.1084/jem.147.5.1299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Zarling J. M., Eskra L., Borden E. C., Horoszewicz J., Carter W. A. Activation of human natural killer cells cytotoxic for human leukemia cells by purified interferon. J Immunol. 1979 Jul;123(1):63–70. [PubMed] [Google Scholar]
  34. Zarling J. M., Raich P. C., McKeough M., Bach F. H. Generation of cytotoxic lymphocytes in vitro against autologous human leukaemia cells. Nature. 1976 Aug 19;262(5570):691–693. doi: 10.1038/262691a0. [DOI] [PubMed] [Google Scholar]
  35. Zarling J. M., Robins H. I., Raich P. C., Bach F. H., Bach M. L. Generation of cytotoxic T lymphocytes to autologous human leukaemia cells by sensitisation to pooled allogeneic normal cells. Nature. 1978 Jul 20;274(5668):269–271. doi: 10.1038/274269a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES